Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 55 entries
Sorted by: Best Match Show Resources per page
Literature review on transitions across early childhood and compulsory school settings in Europe

out of school settings

Balduzzi L.
GSID: ZsXD6ZcADgAJ
L Balduzzi, A Lazzari, K Van Laere, C Boudry, M Rezek… - 2019 - amsacta.unibo.it

… The aim of this literature review, conducted as part of the START project, is to deepen the understanding of transitions across ECEC settings – and between these and CSE settings – by critically analysing the findings of empirical...

Cite
Balduzzi, L., Lazzari, A., Van Laere, K., Boudry, C., Rezek, M., Mlinar, M., & McKinnon, E. (2019). Literature review on transitions across early childhood and compulsory school settings in Europe.
Balduzzi, Lucia, et al. "Literature review on transitions across early childhood and compulsory school settings in Europe." (2019).
Copy Download .nbib Format: MLA
COPD: adherence to therapy.

Multidisciplinary respiratory medicine

Sanduzzi A, Balbo P, Candoli P, Catapano GA, Contini P, Mattei A, Puglisi G, Santoiemma L, Stanziola AA.
PMID: 25485108
Multidiscip Respir Med. 2014 Nov 22;9(1):60. doi: 10.1186/2049-6958-9-60. eCollection 2014.

Adherence to medical therapies is a growing issue, so much so that the World Health Organization defined it as "a new pharmacological problem". The main factors affecting compliance are: frequency of administration, rapid onset of action, role of device....

Cite
Sanduzzi A, Balbo P, Candoli P, et al. COPD: adherence to therapy. Multidiscip Respir Med. 2014;9(1):60doi: 10.1186/2049-6958-9-60.
Sanduzzi, A., Balbo, P., Candoli, P., Catapano, G. A., Contini, P., Mattei, A., Puglisi, G., Santoiemma, L., & Stanziola, A. A. (2014). COPD: adherence to therapy. Multidisciplinary respiratory medicine, 9(1), 60. https://doi.org/10.1186/2049-6958-9-60
Sanduzzi, Alessandro, et al. "COPD: adherence to therapy." Multidisciplinary respiratory medicine vol. 9,1 (2014): 60. doi: https://doi.org/10.1186/2049-6958-9-60
Sanduzzi A, Balbo P, Candoli P, Catapano GA, Contini P, Mattei A, Puglisi G, Santoiemma L, Stanziola AA. COPD: adherence to therapy. Multidiscip Respir Med. 2014 Nov 22;9(1):60. doi: 10.1186/2049-6958-9-60. eCollection 2014. PMID: 25485108; PMCID: PMC4256899.
Copy Download .nbib Format: NLM
Structural characterization of an elevated lipid bilayer obtained by stepwise functionalization of a self-assembled alkenyl silane film.

Biointerphases

Daniel C, Sohn KE, Mates TE, Kramer EJ, Rädler JO, Sackmann E, Nickel B, Andruzzi L.
PMID: 20408645
Biointerphases. 2007 Sep;2(3):109-18. doi: 10.1116/1.2790852.

This work reports a novel tethered lipid membrane supported on silicon oxide providing an improved model cell membrane. There is an increasing need for robust solid supported fluid model membranes that can be easily deposited on soft cushions. In...

Cite
Daniel C, Sohn KE, Mates TE, et al. Structural characterization of an elevated lipid bilayer obtained by stepwise functionalization of a self-assembled alkenyl silane film. Biointerphases. 2007;2(3):109-18doi: 10.1116/1.2790852.
Daniel, C., Sohn, K. E., Mates, T. E., Kramer, E. J., Rädler, J. O., Sackmann, E., Nickel, B., & Andruzzi, L. (2007). Structural characterization of an elevated lipid bilayer obtained by stepwise functionalization of a self-assembled alkenyl silane film. Biointerphases, 2(3), 109-18. https://doi.org/10.1116/1.2790852
Daniel, Christian, et al. "Structural characterization of an elevated lipid bilayer obtained by stepwise functionalization of a self-assembled alkenyl silane film." Biointerphases vol. 2,3 (2007): 109-18. doi: https://doi.org/10.1116/1.2790852
Daniel C, Sohn KE, Mates TE, Kramer EJ, Rädler JO, Sackmann E, Nickel B, Andruzzi L. Structural characterization of an elevated lipid bilayer obtained by stepwise functionalization of a self-assembled alkenyl silane film. Biointerphases. 2007 Sep;2(3):109-18. doi: 10.1116/1.2790852. PMID: 20408645.
Copy Download .nbib Format: NLM
Harvey Alan Lincoff, M.D. 1920-2017 a pioneer of ophthalmology.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Kreissig I, Yannuzzi L, Jackson Coleman D, Chang S.
PMID: 29374795
Graefes Arch Clin Exp Ophthalmol. 2018 Mar;256(3):449-450. doi: 10.1007/s00417-018-3911-2.

No abstract available.

Cite
Kreissig I, Yannuzzi L, Jackson Coleman D, et al. Harvey Alan Lincoff, M.D. 1920-2017 a pioneer of ophthalmology. Graefes Arch Clin Exp Ophthalmol. 2018;256(3):449-450doi: 10.1007/s00417-018-3911-2.
Kreissig, I., Yannuzzi, L., Jackson Coleman, D., & Chang, S. (2018). Harvey Alan Lincoff, M.D. 1920-2017 a pioneer of ophthalmology. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 256(3), 449-450. https://doi.org/10.1007/s00417-018-3911-2
Kreissig, Ingrid, et al. "Harvey Alan Lincoff, M.D. 1920-2017 a pioneer of ophthalmology." Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie vol. 256,3 (2018): 449-450. doi: https://doi.org/10.1007/s00417-018-3911-2
Kreissig I, Yannuzzi L, Jackson Coleman D, Chang S. Harvey Alan Lincoff, M.D. 1920-2017 a pioneer of ophthalmology. Graefes Arch Clin Exp Ophthalmol. 2018 Mar;256(3):449-450. doi: 10.1007/s00417-018-3911-2. PMID: 29374795.
Copy Download .nbib Format: NLM
Local allergic rhinitis: entopy or spontaneous response?.

The World Allergy Organization journal

Gelardi M, Guglielmi AV, Iannuzzi L, Quaranta VN, Quaranta N, Landi M, Correale M, Sonnante A, Rossini M, Mariggiò MA, Canonica GW, Passalacqua G.
PMID: 27980704
World Allergy Organ J. 2016 Dec 06;9(1):39. doi: 10.1186/s40413-016-0126-z. eCollection 2016.

BACKGROUND: The existence of a local allergic rhintis was proposed on the basis of the detection of nasal IgE in the absence of a systemic sensitization. Nevertheless, the significance of this phenomenon remains still unclear. We assessed the presence...

Cite
Gelardi M, Guglielmi AV, Iannuzzi L, et al. Local allergic rhinitis: entopy or spontaneous response?. World Allergy Organ J. 2016;9(1):39doi: 10.1186/s40413-016-0126-z.
Gelardi, M., Guglielmi, A. V., Iannuzzi, L., Quaranta, V. N., Quaranta, N., Landi, M., Correale, M., Sonnante, A., Rossini, M., Mariggiò, M. A., Canonica, G. W., & Passalacqua, G. (2016). Local allergic rhinitis: entopy or spontaneous response?. The World Allergy Organization journal, 9(1), 39. https://doi.org/10.1186/s40413-016-0126-z
Gelardi, Matteo, et al. "Local allergic rhinitis: entopy or spontaneous response?." The World Allergy Organization journal vol. 9,1 (2016): 39. doi: https://doi.org/10.1186/s40413-016-0126-z
Gelardi M, Guglielmi AV, Iannuzzi L, Quaranta VN, Quaranta N, Landi M, Correale M, Sonnante A, Rossini M, Mariggiò MA, Canonica GW, Passalacqua G. Local allergic rhinitis: entopy or spontaneous response?. World Allergy Organ J. 2016 Dec 06;9(1):39. doi: 10.1186/s40413-016-0126-z. eCollection 2016. PMID: 27980704; PMCID: PMC5139012.
Copy Download .nbib Format: NLM
Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report.

Medicines (Basel, Switzerland)

Massucci M, Mollica V, Rizzo A, Ventrella L, Maggio I, Manuzzi L, Gatto L, Brandi G, Massari F.
PMID: 33440621
Medicines (Basel). 2021 Jan 11;8(1). doi: 10.3390/medicines8010005.

Renal cell carcinoma is a malignant tumor that arises in the kidney parenchyma. For many years, sunitinib has represented the mainstay of medical treatment for metastatic renal cell carcinoma. Herein, we present the case of a 66-year-old woman with...

Cite
Massucci M, Mollica V, Rizzo A, et al. Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report. Medicines (Basel). 2021;8(1)doi: 10.3390/medicines8010005.
Massucci, M., Mollica, V., Rizzo, A., Ventrella, L., Maggio, I., Manuzzi, L., Gatto, L., Brandi, G., & Massari, F. (2021). Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report. Medicines (Basel, Switzerland), 8(1), . https://doi.org/10.3390/medicines8010005
Massucci, Maria, et al. "Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report." Medicines (Basel, Switzerland) vol. 8,1 (2021). doi: https://doi.org/10.3390/medicines8010005
Massucci M, Mollica V, Rizzo A, Ventrella L, Maggio I, Manuzzi L, Gatto L, Brandi G, Massari F. Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report. Medicines (Basel). 2021 Jan 11;8(1). doi: 10.3390/medicines8010005. PMID: 33440621; PMCID: PMC7826710.
Copy Download .nbib Format: NLM
A common microbial signature is present in the lower airways of interstitial lung diseases including sarcoidosis.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG

D'Argenio V, Casaburi G, Precone V, Gioacchino Moccia L, Postiglione I, Bocchino M, Sanduzzi A.
PMID: 32476923
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(4):354-362. doi: 10.36141/svdld.v35i4.7061. Epub 2020 Mar 09.

No abstract available.

Cite
D'Argenio V, Casaburi G, Precone V, et al. A common microbial signature is present in the lower airways of interstitial lung diseases including sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2020;35(4):354-362doi: 10.36141/svdld.v35i4.7061.
D'Argenio, V., Casaburi, G., Precone, V., Gioacchino Moccia, L., Postiglione, I., Bocchino, M., & Sanduzzi, A. (2018). A common microbial signature is present in the lower airways of interstitial lung diseases including sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 35(4), 354-362. https://doi.org/10.36141/svdld.v35i4.7061
D'Argenio, Valeria, et al. "A common microbial signature is present in the lower airways of interstitial lung diseases including sarcoidosis." Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG vol. 35,4 (2018): 354-362. doi: https://doi.org/10.36141/svdld.v35i4.7061
D'Argenio V, Casaburi G, Precone V, Gioacchino Moccia L, Postiglione I, Bocchino M, Sanduzzi A. A common microbial signature is present in the lower airways of interstitial lung diseases including sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(4):354-362. doi: 10.36141/svdld.v35i4.7061. Epub 2020 Mar 09. PMID: 32476923; PMCID: PMC7170129.
Copy Download .nbib Format: NLM
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.

Molecular cancer therapeutics

Balestra T, Manara MC, Laginestra MA, Pasello M, De Feo A, Bassi C, Guerzoni C, Landuzzi L, Lollini PL, Donati DM, Negrini M, Magnani M, Scotlandi K.
PMID: 34667115
Mol Cancer Ther. 2021 Oct 19; doi: 10.1158/1535-7163.MCT-21-0189. Epub 2021 Oct 19.

Ewing sarcoma, a highly aggressive pediatric tumor, is driven by EWS-FLI1, an oncogenic transcription factor that remodels the tumor genetic landscape. Epigenetic mechanisms play a pivotal role in Ewing sarcoma pathogenesis, and the therapeutic value of compounds targeting epigenetic...

Cite
Balestra T, Manara MC, Laginestra MA, et al. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity. Mol Cancer Ther. 2021;doi: 10.1158/1535-7163.MCT-21-0189.
Balestra, T., Manara, M. C., Laginestra, M. A., Pasello, M., De Feo, A., Bassi, C., Guerzoni, C., Landuzzi, L., Lollini, P. L., Donati, D. M., Negrini, M., Magnani, M., & Scotlandi, K. (2021). Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity. Molecular cancer therapeutics, . https://doi.org/10.1158/1535-7163.MCT-21-0189
Balestra, Tommaso, et al. "Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity." Molecular cancer therapeutics vol. (2021). doi: https://doi.org/10.1158/1535-7163.MCT-21-0189
Balestra T, Manara MC, Laginestra MA, Pasello M, De Feo A, Bassi C, Guerzoni C, Landuzzi L, Lollini PL, Donati DM, Negrini M, Magnani M, Scotlandi K. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity. Mol Cancer Ther. 2021 Oct 19; doi: 10.1158/1535-7163.MCT-21-0189. Epub 2021 Oct 19. PMID: 34667115.
Copy Download .nbib Format: NLM
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression.

Oncogenesis

Giusti V, Ruzzi F, Landuzzi L, Ianzano ML, Laranga R, Nironi E, Scalambra L, Nicoletti G, De Giovanni C, Olivero M, Arigoni M, Calogero R, Nanni P, Palladini A, Lollini PL.
PMID: 34775465
Oncogenesis. 2021 Nov 13;10(11):77. doi: 10.1038/s41389-021-00360-9.

HER2-positive breast cancers may lose HER2 expression in recurrences and metastases. In this work, we studied cell lines derived from two transgenic mammary tumors driven by human HER2 that showed different dynamics of HER2 status. MamBo89HER2

Cite
Giusti V, Ruzzi F, Landuzzi L, et al. Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression. Oncogenesis. 2021;10(11):77doi: 10.1038/s41389-021-00360-9.
Giusti, V., Ruzzi, F., Landuzzi, L., Ianzano, M. L., Laranga, R., Nironi, E., Scalambra, L., Nicoletti, G., De Giovanni, C., Olivero, M., Arigoni, M., Calogero, R., Nanni, P., Palladini, A., & Lollini, P. L. (2021). Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression. Oncogenesis, 10(11), 77. https://doi.org/10.1038/s41389-021-00360-9
Giusti, Veronica, et al. "Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression." Oncogenesis vol. 10,11 (2021): 77. doi: https://doi.org/10.1038/s41389-021-00360-9
Giusti V, Ruzzi F, Landuzzi L, Ianzano ML, Laranga R, Nironi E, Scalambra L, Nicoletti G, De Giovanni C, Olivero M, Arigoni M, Calogero R, Nanni P, Palladini A, Lollini PL. Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression. Oncogenesis. 2021 Nov 13;10(11):77. doi: 10.1038/s41389-021-00360-9. PMID: 34775465; PMCID: PMC8590694.
Copy Download .nbib Format: NLM
Chronic central serous chorioretinopathy and fundus autofluorescence.

Retinal cases & brief reports

Ho IV, Yannuzzi L.
PMID: 25389602
Retin Cases Brief Rep. 2008;2(1):1-5. doi: 10.1097/ICB.0b013e318074bc8c.

BACKGROUND: Chronic presentations of central serous chorioretinopathy (CSC) may be associated with large serous retinal detachments and subretinal exudates. The exudates are believed to be fibrin in acute disease and lipid in chronic detachments. Fundus autofluorescence (FAF) imaging has...

Cite
Ho IV, Yannuzzi L. Chronic central serous chorioretinopathy and fundus autofluorescence. Retin Cases Brief Rep. 2008;2(1):1-5doi: 10.1097/ICB.0b013e318074bc8c.
Ho, I. V., & Yannuzzi, L. (2008). Chronic central serous chorioretinopathy and fundus autofluorescence. Retinal cases & brief reports, 2(1), 1-5. https://doi.org/10.1097/ICB.0b013e318074bc8c
Ho, I-Van, and Yannuzzi, Lawrence. "Chronic central serous chorioretinopathy and fundus autofluorescence." Retinal cases & brief reports vol. 2,1 (2008): 1-5. doi: https://doi.org/10.1097/ICB.0b013e318074bc8c
Ho IV, Yannuzzi L. Chronic central serous chorioretinopathy and fundus autofluorescence. Retin Cases Brief Rep. 2008;2(1):1-5. doi: 10.1097/ICB.0b013e318074bc8c. PMID: 25389602.
Copy Download .nbib Format: NLM
Ammonium Fluoride as Suitable Additive for HILIC-Based LC-HRMS Metabolomics.

Metabolites

Narduzzi L, Royer AL, Bichon E, Guitton Y, Buisson C, Le Bizec B, Dervilly-Pinel G.
PMID: 31783638
Metabolites. 2019 Nov 27;9(12). doi: 10.3390/metabo9120292.

Hydrophilic Interaction Liquid Chromatography (HILIC) chromatography is widely applied in metabolomics as a complementary strategy to reverse phase chromatography. Nevertheless, it still faces several issues in terms of peak shape and compounds ionization, limiting the automatic de-convolution and data...

Cite
Narduzzi L, Royer AL, Bichon E, et al. Ammonium Fluoride as Suitable Additive for HILIC-Based LC-HRMS Metabolomics. Metabolites. 2019;9(12)doi: 10.3390/metabo9120292.
Narduzzi, L., Royer, A. L., Bichon, E., Guitton, Y., Buisson, C., Le Bizec, B., & Dervilly-Pinel, G. (2019). Ammonium Fluoride as Suitable Additive for HILIC-Based LC-HRMS Metabolomics. Metabolites, 9(12), . https://doi.org/10.3390/metabo9120292
Narduzzi, Luca, et al. "Ammonium Fluoride as Suitable Additive for HILIC-Based LC-HRMS Metabolomics." Metabolites vol. 9,12 (2019). doi: https://doi.org/10.3390/metabo9120292
Narduzzi L, Royer AL, Bichon E, Guitton Y, Buisson C, Le Bizec B, Dervilly-Pinel G. Ammonium Fluoride as Suitable Additive for HILIC-Based LC-HRMS Metabolomics. Metabolites. 2019 Nov 27;9(12). doi: 10.3390/metabo9120292. PMID: 31783638; PMCID: PMC6950006.
Copy Download .nbib Format: NLM
Virus-like particle display of HER2 induces potent anti-cancer responses.

Oncoimmunology

Palladini A, Thrane S, Janitzek CM, Pihl J, Clemmensen SB, de Jongh WA, Clausen TM, Nicoletti G, Landuzzi L, Penichet ML, Balboni T, Ianzano ML, Giusti V, Theander TG, Nielsen MA, Salanti A, Lollini PL, Nanni P, Sander AF.
PMID: 29399414
Oncoimmunology. 2018 Jan 05;7(3):e1408749. doi: 10.1080/2162402X.2017.1408749. eCollection 2018.

Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20-30% of invasive breast cancers. Monoclonal antibody therapy is effective in treating HER2-driven mammary carcinomas, but its utility is limited by high costs, side effects and development of resistance....

Cite
Palladini A, Thrane S, Janitzek CM, et al. Virus-like particle display of HER2 induces potent anti-cancer responses. Oncoimmunology. 2018;7(3):e1408749doi: 10.1080/2162402X.2017.1408749.
Palladini, A., Thrane, S., Janitzek, C. M., Pihl, J., Clemmensen, S. B., de Jongh, W. A., Clausen, T. M., Nicoletti, G., Landuzzi, L., Penichet, M. L., Balboni, T., Ianzano, M. L., Giusti, V., Theander, T. G., Nielsen, M. A., Salanti, A., Lollini, P. L., Nanni, P., & Sander, A. F. (2018). Virus-like particle display of HER2 induces potent anti-cancer responses. Oncoimmunology, 7(3), e1408749. https://doi.org/10.1080/2162402X.2017.1408749
Palladini, Arianna, et al. "Virus-like particle display of HER2 induces potent anti-cancer responses." Oncoimmunology vol. 7,3 (2018): e1408749. doi: https://doi.org/10.1080/2162402X.2017.1408749
Palladini A, Thrane S, Janitzek CM, Pihl J, Clemmensen SB, de Jongh WA, Clausen TM, Nicoletti G, Landuzzi L, Penichet ML, Balboni T, Ianzano ML, Giusti V, Theander TG, Nielsen MA, Salanti A, Lollini PL, Nanni P, Sander AF. Virus-like particle display of HER2 induces potent anti-cancer responses. Oncoimmunology. 2018 Jan 05;7(3):e1408749. doi: 10.1080/2162402X.2017.1408749. eCollection 2018. PMID: 29399414; PMCID: PMC5790387.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 55 entries